Status: Recruiting
A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of SFL-0821 in adult patients with Facioscapulohumeral Muscular Dystrophy (FSHD)
Participants needed: 90
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Soufflé Therapeutics, Inc.Updated: Oct 9, 2026Locations: 6
Eligibility criteria
Genetically confirmed diagnosis of FSHD 1 or 2 [+3]
History of any illness or any clinical condition that, in the opinion of the Inv... [+2]